nodes	percent_of_prediction	percent_of_DWPC	metapath
Irinotecan—Topotecan—lung cancer	0.255	1	CrCtD
Irinotecan—colon cancer—lung cancer	0.133	1	CtDrD
Irinotecan—Topoisomerase Inhibitors—Teniposide—lung cancer	0.101	0.349	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Topotecan—lung cancer	0.09	0.311	CiPCiCtD
Irinotecan—Topoisomerase Inhibitors—Etoposide—lung cancer	0.06	0.208	CiPCiCtD
Irinotecan—TOP1—lung cancer	0.0567	0.49	CbGaD
Irinotecan—TOP1MT—Topotecan—lung cancer	0.0493	0.351	CbGbCtD
Irinotecan—Topoisomerase Inhibitors—Doxorubicin—lung cancer	0.0382	0.132	CiPCiCtD
Irinotecan—UGT1A1—lung cancer	0.0289	0.25	CbGaD
Irinotecan—TOP1—Topotecan—lung cancer	0.0283	0.202	CbGbCtD
Irinotecan—ABCG2—lung cancer	0.0162	0.14	CbGaD
Irinotecan—ALB—lung cancer	0.00708	0.0612	CbGaD
Irinotecan—ABCB1—lung cancer	0.00676	0.0584	CbGaD
Irinotecan—ABCG2—Topotecan—lung cancer	0.00268	0.0191	CbGbCtD
Irinotecan—UGT1A1—Erlotinib—lung cancer	0.00264	0.0188	CbGbCtD
Irinotecan—ABCG2—Gefitinib—lung cancer	0.00246	0.0175	CbGbCtD
Irinotecan—ABCG2—Teniposide—lung cancer	0.00238	0.017	CbGbCtD
Irinotecan—ABCC1—Paclitaxel—lung cancer	0.00199	0.0142	CbGbCtD
Irinotecan—UGT1A1—Etoposide—lung cancer	0.00191	0.0136	CbGbCtD
Irinotecan—ABCC1—Vinblastine—lung cancer	0.00174	0.0124	CbGbCtD
Irinotecan—ALB—Gefitinib—lung cancer	0.00169	0.0121	CbGbCtD
Irinotecan—ABCC1—Etoposide—lung cancer	0.00157	0.0112	CbGbCtD
Irinotecan—BCHE—Cisplatin—lung cancer	0.00152	0.0108	CbGbCtD
Irinotecan—ABCC2—Paclitaxel—lung cancer	0.00147	0.0105	CbGbCtD
Irinotecan—ABCG2—Erlotinib—lung cancer	0.00145	0.0103	CbGbCtD
Irinotecan—ABCC1—Docetaxel—lung cancer	0.00144	0.0102	CbGbCtD
Irinotecan—CYP3A5—Gefitinib—lung cancer	0.00136	0.0097	CbGbCtD
Irinotecan—ABCG2—Paclitaxel—lung cancer	0.00133	0.00947	CbGbCtD
Irinotecan—CYP3A5—Teniposide—lung cancer	0.00132	0.0094	CbGbCtD
Irinotecan—ABCC2—Vinblastine—lung cancer	0.00129	0.00919	CbGbCtD
Irinotecan—ABCC2—Cisplatin—lung cancer	0.00118	0.00843	CbGbCtD
Irinotecan—ABCC2—Etoposide—lung cancer	0.00116	0.00828	CbGbCtD
Irinotecan—ABCC1—Doxorubicin—lung cancer	0.00107	0.00763	CbGbCtD
Irinotecan—ABCG2—Cisplatin—lung cancer	0.00107	0.00762	CbGbCtD
Irinotecan—ABCC2—Docetaxel—lung cancer	0.00106	0.00757	CbGbCtD
Irinotecan—ABCG2—Etoposide—lung cancer	0.00105	0.00748	CbGbCtD
Irinotecan—ABCC1—Methotrexate—lung cancer	0.00104	0.00739	CbGbCtD
Irinotecan—ALB—Erlotinib—lung cancer	0.001	0.00713	CbGbCtD
Irinotecan—CYP3A7—Paclitaxel—lung cancer	0.000982	0.007	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.000982	0.007	CbGbCtD
Irinotecan—ABCB1—Topotecan—lung cancer	0.000968	0.0069	CbGbCtD
Irinotecan—ABCG2—Docetaxel—lung cancer	0.000961	0.00685	CbGbCtD
Irinotecan—ABCB1—Gefitinib—lung cancer	0.000885	0.00631	CbGbCtD
Irinotecan—SLCO1B1—Methotrexate—lung cancer	0.000873	0.00622	CbGbCtD
Irinotecan—CYP3A5—Crizotinib—lung cancer	0.000834	0.00594	CbGbCtD
Irinotecan—Topotecan—TOP1—lung cancer	0.00081	0.712	CrCbGaD
Irinotecan—BCHE—diaphragm—lung cancer	0.000807	0.117	CbGeAlD
Irinotecan—CYP3A5—Erlotinib—lung cancer	0.000804	0.00573	CbGbCtD
Irinotecan—ABCC2—Doxorubicin—lung cancer	0.000792	0.00565	CbGbCtD
Irinotecan—ABCC2—Methotrexate—lung cancer	0.000767	0.00547	CbGbCtD
Irinotecan—CYP2B6—Cisplatin—lung cancer	0.000752	0.00536	CbGbCtD
Irinotecan—CYP3A5—Paclitaxel—lung cancer	0.000736	0.00525	CbGbCtD
Irinotecan—ABCG2—Doxorubicin—lung cancer	0.000716	0.0051	CbGbCtD
Irinotecan—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00071	0.00506	CbGbCtD
Irinotecan—CYP3A7—Docetaxel—lung cancer	0.00071	0.00506	CbGbCtD
Irinotecan—ABCG2—Methotrexate—lung cancer	0.000694	0.00494	CbGbCtD
Irinotecan—ABCB1—Vinorelbine—lung cancer	0.000682	0.00486	CbGbCtD
Irinotecan—CYP3A5—Etoposide—lung cancer	0.000582	0.00415	CbGbCtD
Irinotecan—CYP3A4—Topotecan—lung cancer	0.00058	0.00413	CbGbCtD
Irinotecan—ABCB1—Crizotinib—lung cancer	0.000543	0.00387	CbGbCtD
Irinotecan—CYP3A5—Docetaxel—lung cancer	0.000532	0.00379	CbGbCtD
Irinotecan—CYP3A4—Gefitinib—lung cancer	0.00053	0.00378	CbGbCtD
Irinotecan—ABCB1—Gemcitabine—lung cancer	0.00053	0.00378	CbGbCtD
Irinotecan—ABCB1—Erlotinib—lung cancer	0.000523	0.00373	CbGbCtD
Irinotecan—CYP3A4—Teniposide—lung cancer	0.000514	0.00367	CbGbCtD
Irinotecan—CYP2B6—Doxorubicin—lung cancer	0.000504	0.00359	CbGbCtD
Irinotecan—ABCB1—Paclitaxel—lung cancer	0.000479	0.00342	CbGbCtD
Irinotecan—ALB—Methotrexate—lung cancer	0.000478	0.00341	CbGbCtD
Irinotecan—TOP1MT—respiratory system—lung cancer	0.000476	0.0688	CbGeAlD
Irinotecan—ABCB1—Vinblastine—lung cancer	0.00042	0.003	CbGbCtD
Irinotecan—CYP3A4—Vinorelbine—lung cancer	0.000409	0.00291	CbGbCtD
Irinotecan—ABCB1—Cisplatin—lung cancer	0.000385	0.00275	CbGbCtD
Irinotecan—ABCB1—Etoposide—lung cancer	0.000379	0.0027	CbGbCtD
Irinotecan—TOP1—mammary gland—lung cancer	0.000377	0.0545	CbGeAlD
Irinotecan—ABCB1—Docetaxel—lung cancer	0.000346	0.00247	CbGbCtD
Irinotecan—CES2—mammary gland—lung cancer	0.000342	0.0494	CbGeAlD
Irinotecan—CYP3A4—Crizotinib—lung cancer	0.000325	0.00232	CbGbCtD
Irinotecan—CYP3A4—Erlotinib—lung cancer	0.000314	0.00224	CbGbCtD
Irinotecan—CYP3A4—Paclitaxel—lung cancer	0.000287	0.00205	CbGbCtD
Irinotecan—ABCB1—Doxorubicin—lung cancer	0.000258	0.00184	CbGbCtD
Irinotecan—TOP1MT—lung—lung cancer	0.000253	0.0365	CbGeAlD
Irinotecan—CYP3A4—Vinblastine—lung cancer	0.000252	0.00179	CbGbCtD
Irinotecan—ABCB1—Methotrexate—lung cancer	0.00025	0.00178	CbGbCtD
Irinotecan—SLCO1B1—mammary gland—lung cancer	0.000242	0.0349	CbGeAlD
Irinotecan—Topotecan—ABCG2—lung cancer	0.000232	0.204	CrCbGaD
Irinotecan—CES2—respiratory system—lung cancer	0.000228	0.0329	CbGeAlD
Irinotecan—CYP3A4—Etoposide—lung cancer	0.000227	0.00162	CbGbCtD
Irinotecan—CYP3A4—Docetaxel—lung cancer	0.000208	0.00148	CbGbCtD
Irinotecan—TOP1—bronchus—lung cancer	0.000207	0.0299	CbGeAlD
Irinotecan—ALB—mammary gland—lung cancer	0.000196	0.0283	CbGeAlD
Irinotecan—CES1—respiratory system—lung cancer	0.000188	0.0271	CbGeAlD
Irinotecan—CES2—bronchus—lung cancer	0.000187	0.0271	CbGeAlD
Irinotecan—TOP1—trachea—lung cancer	0.000186	0.0268	CbGeAlD
Irinotecan—TOP1—cardiac atrium—lung cancer	0.000174	0.0252	CbGeAlD
Irinotecan—TOP1MT—lymph node—lung cancer	0.000173	0.025	CbGeAlD
Irinotecan—CES2—trachea—lung cancer	0.000168	0.0243	CbGeAlD
Irinotecan—CES2—cardiac atrium—lung cancer	0.000158	0.0229	CbGeAlD
Irinotecan—CYP3A4—Doxorubicin—lung cancer	0.000155	0.0011	CbGbCtD
Irinotecan—TOP1—bone marrow—lung cancer	0.000147	0.0213	CbGeAlD
Irinotecan—CES2—bone marrow—lung cancer	0.000133	0.0193	CbGeAlD
Irinotecan—TOP1—lung—lung cancer	0.000133	0.0193	CbGeAlD
Irinotecan—CES2—lung—lung cancer	0.000121	0.0175	CbGeAlD
Irinotecan—CES1—lung—lung cancer	9.96e-05	0.0144	CbGeAlD
Irinotecan—Topotecan—ABCB1—lung cancer	9.65e-05	0.0848	CrCbGaD
Irinotecan—BCHE—respiratory system—lung cancer	9.22e-05	0.0133	CbGeAlD
Irinotecan—TOP1—lymph node—lung cancer	9.12e-05	0.0132	CbGeAlD
Irinotecan—ABCC1—bronchus—lung cancer	8.86e-05	0.0128	CbGeAlD
Irinotecan—CES2—lymph node—lung cancer	8.27e-05	0.012	CbGeAlD
Irinotecan—CYP3A5—respiratory system—lung cancer	8.27e-05	0.012	CbGeAlD
Irinotecan—CYP2B6—respiratory system—lung cancer	8.22e-05	0.0119	CbGeAlD
Irinotecan—ABCC1—trachea—lung cancer	7.95e-05	0.0115	CbGeAlD
Irinotecan—BCHE—bronchus—lung cancer	7.59e-05	0.011	CbGeAlD
Irinotecan—ABCC1—cardiac atrium—lung cancer	7.47e-05	0.0108	CbGeAlD
Irinotecan—SLC22A3—lung—lung cancer	6.91e-05	0.00999	CbGeAlD
Irinotecan—BCHE—trachea—lung cancer	6.81e-05	0.00984	CbGeAlD
Irinotecan—CES1—lymph node—lung cancer	6.81e-05	0.00984	CbGeAlD
Irinotecan—ACHE—lymph node—lung cancer	6.81e-05	0.00984	CbGeAlD
Irinotecan—CYP2B6—bronchus—lung cancer	6.76e-05	0.00978	CbGeAlD
Irinotecan—BCHE—cardiac atrium—lung cancer	6.4e-05	0.00925	CbGeAlD
Irinotecan—ABCC1—lung—lung cancer	5.71e-05	0.00826	CbGeAlD
Irinotecan—BCHE—bone marrow—lung cancer	5.4e-05	0.00781	CbGeAlD
Irinotecan—ABCG2—bone marrow—lung cancer	5.22e-05	0.00755	CbGeAlD
Irinotecan—BCHE—lung—lung cancer	4.89e-05	0.00707	CbGeAlD
Irinotecan—ALB—lymph node—lung cancer	4.74e-05	0.00684	CbGeAlD
Irinotecan—ABCG2—lung—lung cancer	4.73e-05	0.00684	CbGeAlD
Irinotecan—SLC22A3—lymph node—lung cancer	4.73e-05	0.00683	CbGeAlD
Irinotecan—ABCC2—lymph node—lung cancer	4.44e-05	0.00641	CbGeAlD
Irinotecan—ABCB1—respiratory system—lung cancer	4.39e-05	0.00635	CbGeAlD
Irinotecan—CYP3A5—lung—lung cancer	4.39e-05	0.00635	CbGeAlD
Irinotecan—CYP2B6—lung—lung cancer	4.36e-05	0.00631	CbGeAlD
Irinotecan—ABCC1—lymph node—lung cancer	3.91e-05	0.00565	CbGeAlD
Irinotecan—ABCB1—epithelium—lung cancer	3.67e-05	0.00531	CbGeAlD
Irinotecan—BCHE—lymph node—lung cancer	3.35e-05	0.00484	CbGeAlD
Irinotecan—ABCB1—trachea—lung cancer	3.25e-05	0.00469	CbGeAlD
Irinotecan—ABCG2—lymph node—lung cancer	3.24e-05	0.00468	CbGeAlD
Irinotecan—ABCB1—bone marrow—lung cancer	2.57e-05	0.00372	CbGeAlD
Irinotecan—ABCB1—lung—lung cancer	2.33e-05	0.00337	CbGeAlD
Irinotecan—ABCB1—lymph node—lung cancer	1.6e-05	0.00231	CbGeAlD
Irinotecan—Anaphylactic shock—Paclitaxel—lung cancer	1.09e-05	0.000302	CcSEcCtD
Irinotecan—Paraesthesia—Cisplatin—lung cancer	1.09e-05	0.000302	CcSEcCtD
Irinotecan—Thrombocytopenia—Etoposide—lung cancer	1.08e-05	0.000302	CcSEcCtD
Irinotecan—Muscle spasms—Docetaxel—lung cancer	1.08e-05	0.000302	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Methotrexate—lung cancer	1.08e-05	0.000302	CcSEcCtD
Irinotecan—Infection—Paclitaxel—lung cancer	1.08e-05	0.0003	CcSEcCtD
Irinotecan—Dyspnoea—Cisplatin—lung cancer	1.08e-05	0.0003	CcSEcCtD
Irinotecan—Hyperhidrosis—Etoposide—lung cancer	1.07e-05	0.000298	CcSEcCtD
Irinotecan—Feeling abnormal—Gemcitabine—lung cancer	1.07e-05	0.000298	CcSEcCtD
Irinotecan—Shock—Paclitaxel—lung cancer	1.07e-05	0.000297	CcSEcCtD
Irinotecan—Dizziness—Vinorelbine—lung cancer	1.07e-05	0.000297	CcSEcCtD
Irinotecan—Orthostatic hypotension—Doxorubicin—lung cancer	1.07e-05	0.000297	CcSEcCtD
Irinotecan—Nervous system disorder—Paclitaxel—lung cancer	1.06e-05	0.000296	CcSEcCtD
Irinotecan—Hypokalaemia—Doxorubicin—lung cancer	1.06e-05	0.000296	CcSEcCtD
Irinotecan—Thrombocytopenia—Paclitaxel—lung cancer	1.06e-05	0.000296	CcSEcCtD
Irinotecan—Anorexia—Etoposide—lung cancer	1.06e-05	0.000294	CcSEcCtD
Irinotecan—Aspartate aminotransferase increased—Doxorubicin—lung cancer	1.05e-05	0.000293	CcSEcCtD
Irinotecan—Decreased appetite—Cisplatin—lung cancer	1.05e-05	0.000293	CcSEcCtD
Irinotecan—Hyperhidrosis—Paclitaxel—lung cancer	1.05e-05	0.000292	CcSEcCtD
Irinotecan—Pneumonia—Methotrexate—lung cancer	1.05e-05	0.000291	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Cisplatin—lung cancer	1.04e-05	0.000291	CcSEcCtD
Irinotecan—Anaemia—Docetaxel—lung cancer	1.04e-05	0.00029	CcSEcCtD
Irinotecan—Anorexia—Paclitaxel—lung cancer	1.04e-05	0.000288	CcSEcCtD
Irinotecan—Hypotension—Etoposide—lung cancer	1.03e-05	0.000288	CcSEcCtD
Irinotecan—Pain—Cisplatin—lung cancer	1.03e-05	0.000288	CcSEcCtD
Irinotecan—Vomiting—Vinorelbine—lung cancer	1.03e-05	0.000286	CcSEcCtD
Irinotecan—Body temperature increased—Gemcitabine—lung cancer	1.03e-05	0.000285	CcSEcCtD
Irinotecan—Renal failure—Methotrexate—lung cancer	1.02e-05	0.000285	CcSEcCtD
Irinotecan—Rash—Vinorelbine—lung cancer	1.02e-05	0.000283	CcSEcCtD
Irinotecan—Dermatitis—Vinorelbine—lung cancer	1.02e-05	0.000283	CcSEcCtD
Irinotecan—Abdominal distension—Doxorubicin—lung cancer	1.02e-05	0.000283	CcSEcCtD
Irinotecan—Hypotension—Paclitaxel—lung cancer	1.01e-05	0.000282	CcSEcCtD
Irinotecan—Stomatitis—Methotrexate—lung cancer	1.01e-05	0.000282	CcSEcCtD
Irinotecan—Headache—Vinorelbine—lung cancer	1.01e-05	0.000282	CcSEcCtD
Irinotecan—Syncope—Docetaxel—lung cancer	1.01e-05	0.000282	CcSEcCtD
Irinotecan—Leukopenia—Docetaxel—lung cancer	1.01e-05	0.000281	CcSEcCtD
Irinotecan—Sweating—Methotrexate—lung cancer	9.97e-06	0.000278	CcSEcCtD
Irinotecan—Feeling abnormal—Cisplatin—lung cancer	9.96e-06	0.000277	CcSEcCtD
Irinotecan—Paraesthesia—Etoposide—lung cancer	9.95e-06	0.000277	CcSEcCtD
Irinotecan—Loss of consciousness—Docetaxel—lung cancer	9.91e-06	0.000276	CcSEcCtD
Irinotecan—Pancreatitis—Doxorubicin—lung cancer	9.9e-06	0.000276	CcSEcCtD
Irinotecan—Dyspnoea—Etoposide—lung cancer	9.87e-06	0.000275	CcSEcCtD
Irinotecan—Somnolence—Etoposide—lung cancer	9.85e-06	0.000274	CcSEcCtD
Irinotecan—Cough—Docetaxel—lung cancer	9.84e-06	0.000274	CcSEcCtD
Irinotecan—Angina pectoris—Doxorubicin—lung cancer	9.84e-06	0.000274	CcSEcCtD
Irinotecan—Insomnia—Paclitaxel—lung cancer	9.82e-06	0.000273	CcSEcCtD
Irinotecan—Paraesthesia—Paclitaxel—lung cancer	9.75e-06	0.000271	CcSEcCtD
Irinotecan—Hypertension—Docetaxel—lung cancer	9.74e-06	0.000271	CcSEcCtD
Irinotecan—Dyspnoea—Paclitaxel—lung cancer	9.68e-06	0.000269	CcSEcCtD
Irinotecan—Somnolence—Paclitaxel—lung cancer	9.65e-06	0.000269	CcSEcCtD
Irinotecan—Decreased appetite—Etoposide—lung cancer	9.63e-06	0.000268	CcSEcCtD
Irinotecan—Nausea—Vinorelbine—lung cancer	9.59e-06	0.000267	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Etoposide—lung cancer	9.56e-06	0.000266	CcSEcCtD
Irinotecan—Dyspepsia—Paclitaxel—lung cancer	9.56e-06	0.000266	CcSEcCtD
Irinotecan—Body temperature increased—Cisplatin—lung cancer	9.56e-06	0.000266	CcSEcCtD
Irinotecan—Fatigue—Etoposide—lung cancer	9.55e-06	0.000266	CcSEcCtD
Irinotecan—Pain—Etoposide—lung cancer	9.47e-06	0.000264	CcSEcCtD
Irinotecan—Constipation—Etoposide—lung cancer	9.47e-06	0.000264	CcSEcCtD
Irinotecan—Neutropenia—Doxorubicin—lung cancer	9.45e-06	0.000263	CcSEcCtD
Irinotecan—Decreased appetite—Paclitaxel—lung cancer	9.44e-06	0.000263	CcSEcCtD
Irinotecan—Upper respiratory tract infection—Doxorubicin—lung cancer	9.39e-06	0.000261	CcSEcCtD
Irinotecan—Haemoglobin—Methotrexate—lung cancer	9.39e-06	0.000261	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Paclitaxel—lung cancer	9.38e-06	0.000261	CcSEcCtD
Irinotecan—Fatigue—Paclitaxel—lung cancer	9.36e-06	0.000261	CcSEcCtD
Irinotecan—Haemorrhage—Methotrexate—lung cancer	9.34e-06	0.00026	CcSEcCtD
Irinotecan—Asthenia—Gemcitabine—lung cancer	9.31e-06	0.000259	CcSEcCtD
Irinotecan—Pain—Paclitaxel—lung cancer	9.29e-06	0.000258	CcSEcCtD
Irinotecan—Constipation—Paclitaxel—lung cancer	9.29e-06	0.000258	CcSEcCtD
Irinotecan—Confusional state—Docetaxel—lung cancer	9.28e-06	0.000258	CcSEcCtD
Irinotecan—Anaphylactic shock—Docetaxel—lung cancer	9.2e-06	0.000256	CcSEcCtD
Irinotecan—Oedema—Docetaxel—lung cancer	9.2e-06	0.000256	CcSEcCtD
Irinotecan—Infection—Docetaxel—lung cancer	9.14e-06	0.000255	CcSEcCtD
Irinotecan—Weight decreased—Doxorubicin—lung cancer	9.14e-06	0.000254	CcSEcCtD
Irinotecan—Feeling abnormal—Etoposide—lung cancer	9.13e-06	0.000254	CcSEcCtD
Irinotecan—Pneumonia—Doxorubicin—lung cancer	9.06e-06	0.000252	CcSEcCtD
Irinotecan—Gastrointestinal pain—Etoposide—lung cancer	9.06e-06	0.000252	CcSEcCtD
Irinotecan—Shock—Docetaxel—lung cancer	9.06e-06	0.000252	CcSEcCtD
Irinotecan—Nervous system disorder—Docetaxel—lung cancer	9.03e-06	0.000251	CcSEcCtD
Irinotecan—Thrombocytopenia—Docetaxel—lung cancer	9.01e-06	0.000251	CcSEcCtD
Irinotecan—Visual impairment—Methotrexate—lung cancer	9e-06	0.00025	CcSEcCtD
Irinotecan—Feeling abnormal—Paclitaxel—lung cancer	8.95e-06	0.000249	CcSEcCtD
Irinotecan—Hypersensitivity—Cisplatin—lung cancer	8.91e-06	0.000248	CcSEcCtD
Irinotecan—Gastrointestinal pain—Paclitaxel—lung cancer	8.88e-06	0.000247	CcSEcCtD
Irinotecan—Diarrhoea—Gemcitabine—lung cancer	8.87e-06	0.000247	CcSEcCtD
Irinotecan—Renal failure—Doxorubicin—lung cancer	8.85e-06	0.000246	CcSEcCtD
Irinotecan—Stomatitis—Doxorubicin—lung cancer	8.78e-06	0.000244	CcSEcCtD
Irinotecan—Jaundice—Doxorubicin—lung cancer	8.78e-06	0.000244	CcSEcCtD
Irinotecan—Anorexia—Docetaxel—lung cancer	8.77e-06	0.000244	CcSEcCtD
Irinotecan—Abdominal pain—Etoposide—lung cancer	8.76e-06	0.000244	CcSEcCtD
Irinotecan—Body temperature increased—Etoposide—lung cancer	8.76e-06	0.000244	CcSEcCtD
Irinotecan—Asthenia—Cisplatin—lung cancer	8.67e-06	0.000241	CcSEcCtD
Irinotecan—Cardiac disorder—Methotrexate—lung cancer	8.67e-06	0.000241	CcSEcCtD
Irinotecan—Sweating—Doxorubicin—lung cancer	8.64e-06	0.00024	CcSEcCtD
Irinotecan—Hypotension—Docetaxel—lung cancer	8.6e-06	0.000239	CcSEcCtD
Irinotecan—Body temperature increased—Paclitaxel—lung cancer	8.58e-06	0.000239	CcSEcCtD
Irinotecan—Abdominal pain—Paclitaxel—lung cancer	8.58e-06	0.000239	CcSEcCtD
Irinotecan—Angiopathy—Methotrexate—lung cancer	8.47e-06	0.000236	CcSEcCtD
Irinotecan—Immune system disorder—Methotrexate—lung cancer	8.43e-06	0.000235	CcSEcCtD
Irinotecan—Mediastinal disorder—Methotrexate—lung cancer	8.42e-06	0.000234	CcSEcCtD
Irinotecan—Chills—Methotrexate—lung cancer	8.38e-06	0.000233	CcSEcCtD
Irinotecan—Insomnia—Docetaxel—lung cancer	8.33e-06	0.000232	CcSEcCtD
Irinotecan—Diarrhoea—Cisplatin—lung cancer	8.27e-06	0.00023	CcSEcCtD
Irinotecan—Paraesthesia—Docetaxel—lung cancer	8.27e-06	0.00023	CcSEcCtD
Irinotecan—Alopecia—Methotrexate—lung cancer	8.25e-06	0.00023	CcSEcCtD
Irinotecan—Vomiting—Gemcitabine—lung cancer	8.25e-06	0.00023	CcSEcCtD
Irinotecan—Bradycardia—Doxorubicin—lung cancer	8.23e-06	0.000229	CcSEcCtD
Irinotecan—Dyspnoea—Docetaxel—lung cancer	8.21e-06	0.000228	CcSEcCtD
Irinotecan—Somnolence—Docetaxel—lung cancer	8.18e-06	0.000228	CcSEcCtD
Irinotecan—Rash—Gemcitabine—lung cancer	8.18e-06	0.000228	CcSEcCtD
Irinotecan—Dermatitis—Gemcitabine—lung cancer	8.17e-06	0.000227	CcSEcCtD
Irinotecan—Hypersensitivity—Etoposide—lung cancer	8.16e-06	0.000227	CcSEcCtD
Irinotecan—Haemoglobin—Doxorubicin—lung cancer	8.13e-06	0.000226	CcSEcCtD
Irinotecan—Headache—Gemcitabine—lung cancer	8.13e-06	0.000226	CcSEcCtD
Irinotecan—Rhinitis—Doxorubicin—lung cancer	8.11e-06	0.000226	CcSEcCtD
Irinotecan—Dyspepsia—Docetaxel—lung cancer	8.1e-06	0.000226	CcSEcCtD
Irinotecan—Haemorrhage—Doxorubicin—lung cancer	8.09e-06	0.000225	CcSEcCtD
Irinotecan—Decreased appetite—Docetaxel—lung cancer	8e-06	0.000223	CcSEcCtD
Irinotecan—Hypersensitivity—Paclitaxel—lung cancer	8e-06	0.000223	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Docetaxel—lung cancer	7.95e-06	0.000221	CcSEcCtD
Irinotecan—Asthenia—Etoposide—lung cancer	7.95e-06	0.000221	CcSEcCtD
Irinotecan—Connective tissue disorder—Doxorubicin—lung cancer	7.95e-06	0.000221	CcSEcCtD
Irinotecan—Fatigue—Docetaxel—lung cancer	7.94e-06	0.000221	CcSEcCtD
Irinotecan—Constipation—Docetaxel—lung cancer	7.87e-06	0.000219	CcSEcCtD
Irinotecan—Pain—Docetaxel—lung cancer	7.87e-06	0.000219	CcSEcCtD
Irinotecan—Back pain—Methotrexate—lung cancer	7.86e-06	0.000219	CcSEcCtD
Irinotecan—Visual impairment—Doxorubicin—lung cancer	7.79e-06	0.000217	CcSEcCtD
Irinotecan—Asthenia—Paclitaxel—lung cancer	7.79e-06	0.000217	CcSEcCtD
Irinotecan—Nausea—Gemcitabine—lung cancer	7.7e-06	0.000214	CcSEcCtD
Irinotecan—Vomiting—Cisplatin—lung cancer	7.69e-06	0.000214	CcSEcCtD
Irinotecan—Rash—Cisplatin—lung cancer	7.62e-06	0.000212	CcSEcCtD
Irinotecan—Dermatitis—Cisplatin—lung cancer	7.62e-06	0.000212	CcSEcCtD
Irinotecan—Feeling abnormal—Docetaxel—lung cancer	7.59e-06	0.000211	CcSEcCtD
Irinotecan—Diarrhoea—Etoposide—lung cancer	7.58e-06	0.000211	CcSEcCtD
Irinotecan—Ill-defined disorder—Methotrexate—lung cancer	7.54e-06	0.00021	CcSEcCtD
Irinotecan—Gastrointestinal pain—Docetaxel—lung cancer	7.53e-06	0.00021	CcSEcCtD
Irinotecan—Anaemia—Methotrexate—lung cancer	7.51e-06	0.000209	CcSEcCtD
Irinotecan—Flushing—Doxorubicin—lung cancer	7.5e-06	0.000209	CcSEcCtD
Irinotecan—Cardiac disorder—Doxorubicin—lung cancer	7.5e-06	0.000209	CcSEcCtD
Irinotecan—Diarrhoea—Paclitaxel—lung cancer	7.43e-06	0.000207	CcSEcCtD
Irinotecan—Angiopathy—Doxorubicin—lung cancer	7.34e-06	0.000204	CcSEcCtD
Irinotecan—Malaise—Methotrexate—lung cancer	7.33e-06	0.000204	CcSEcCtD
Irinotecan—Dizziness—Etoposide—lung cancer	7.32e-06	0.000204	CcSEcCtD
Irinotecan—Immune system disorder—Doxorubicin—lung cancer	7.3e-06	0.000203	CcSEcCtD
Irinotecan—Vertigo—Methotrexate—lung cancer	7.3e-06	0.000203	CcSEcCtD
Irinotecan—Mediastinal disorder—Doxorubicin—lung cancer	7.29e-06	0.000203	CcSEcCtD
Irinotecan—Body temperature increased—Docetaxel—lung cancer	7.28e-06	0.000203	CcSEcCtD
Irinotecan—Abdominal pain—Docetaxel—lung cancer	7.28e-06	0.000203	CcSEcCtD
Irinotecan—Leukopenia—Methotrexate—lung cancer	7.28e-06	0.000203	CcSEcCtD
Irinotecan—Chills—Doxorubicin—lung cancer	7.26e-06	0.000202	CcSEcCtD
Irinotecan—Arrhythmia—Doxorubicin—lung cancer	7.22e-06	0.000201	CcSEcCtD
Irinotecan—Dizziness—Paclitaxel—lung cancer	7.18e-06	0.0002	CcSEcCtD
Irinotecan—Nausea—Cisplatin—lung cancer	7.18e-06	0.0002	CcSEcCtD
Irinotecan—Alopecia—Doxorubicin—lung cancer	7.15e-06	0.000199	CcSEcCtD
Irinotecan—Cough—Methotrexate—lung cancer	7.09e-06	0.000197	CcSEcCtD
Irinotecan—Vomiting—Etoposide—lung cancer	7.04e-06	0.000196	CcSEcCtD
Irinotecan—Rash—Etoposide—lung cancer	6.98e-06	0.000194	CcSEcCtD
Irinotecan—Dermatitis—Etoposide—lung cancer	6.98e-06	0.000194	CcSEcCtD
Irinotecan—Headache—Etoposide—lung cancer	6.94e-06	0.000193	CcSEcCtD
Irinotecan—Flatulence—Doxorubicin—lung cancer	6.94e-06	0.000193	CcSEcCtD
Irinotecan—Vomiting—Paclitaxel—lung cancer	6.9e-06	0.000192	CcSEcCtD
Irinotecan—Rash—Paclitaxel—lung cancer	6.85e-06	0.000191	CcSEcCtD
Irinotecan—Dermatitis—Paclitaxel—lung cancer	6.84e-06	0.00019	CcSEcCtD
Irinotecan—Discomfort—Methotrexate—lung cancer	6.84e-06	0.00019	CcSEcCtD
Irinotecan—Back pain—Doxorubicin—lung cancer	6.81e-06	0.00019	CcSEcCtD
Irinotecan—Headache—Paclitaxel—lung cancer	6.8e-06	0.000189	CcSEcCtD
Irinotecan—Hypersensitivity—Docetaxel—lung cancer	6.78e-06	0.000189	CcSEcCtD
Irinotecan—Muscle spasms—Doxorubicin—lung cancer	6.77e-06	0.000188	CcSEcCtD
Irinotecan—Confusional state—Methotrexate—lung cancer	6.69e-06	0.000186	CcSEcCtD
Irinotecan—Anaphylactic shock—Methotrexate—lung cancer	6.63e-06	0.000185	CcSEcCtD
Irinotecan—Asthenia—Docetaxel—lung cancer	6.6e-06	0.000184	CcSEcCtD
Irinotecan—Infection—Methotrexate—lung cancer	6.59e-06	0.000183	CcSEcCtD
Irinotecan—Nausea—Etoposide—lung cancer	6.58e-06	0.000183	CcSEcCtD
Irinotecan—Ill-defined disorder—Doxorubicin—lung cancer	6.53e-06	0.000182	CcSEcCtD
Irinotecan—Nervous system disorder—Methotrexate—lung cancer	6.51e-06	0.000181	CcSEcCtD
Irinotecan—Anaemia—Doxorubicin—lung cancer	6.51e-06	0.000181	CcSEcCtD
Irinotecan—Thrombocytopenia—Methotrexate—lung cancer	6.5e-06	0.000181	CcSEcCtD
Irinotecan—Nausea—Paclitaxel—lung cancer	6.45e-06	0.00018	CcSEcCtD
Irinotecan—Hyperhidrosis—Methotrexate—lung cancer	6.41e-06	0.000179	CcSEcCtD
Irinotecan—Malaise—Doxorubicin—lung cancer	6.35e-06	0.000177	CcSEcCtD
Irinotecan—Vertigo—Doxorubicin—lung cancer	6.32e-06	0.000176	CcSEcCtD
Irinotecan—Anorexia—Methotrexate—lung cancer	6.32e-06	0.000176	CcSEcCtD
Irinotecan—Syncope—Doxorubicin—lung cancer	6.31e-06	0.000176	CcSEcCtD
Irinotecan—Leukopenia—Doxorubicin—lung cancer	6.3e-06	0.000175	CcSEcCtD
Irinotecan—Diarrhoea—Docetaxel—lung cancer	6.3e-06	0.000175	CcSEcCtD
Irinotecan—Hypotension—Methotrexate—lung cancer	6.2e-06	0.000173	CcSEcCtD
Irinotecan—Loss of consciousness—Doxorubicin—lung cancer	6.19e-06	0.000172	CcSEcCtD
Irinotecan—Cough—Doxorubicin—lung cancer	6.14e-06	0.000171	CcSEcCtD
Irinotecan—Dizziness—Docetaxel—lung cancer	6.09e-06	0.000169	CcSEcCtD
Irinotecan—Hypertension—Doxorubicin—lung cancer	6.08e-06	0.000169	CcSEcCtD
Irinotecan—Insomnia—Methotrexate—lung cancer	6e-06	0.000167	CcSEcCtD
Irinotecan—Paraesthesia—Methotrexate—lung cancer	5.96e-06	0.000166	CcSEcCtD
Irinotecan—Discomfort—Doxorubicin—lung cancer	5.92e-06	0.000165	CcSEcCtD
Irinotecan—Dyspnoea—Methotrexate—lung cancer	5.91e-06	0.000165	CcSEcCtD
Irinotecan—Somnolence—Methotrexate—lung cancer	5.9e-06	0.000164	CcSEcCtD
Irinotecan—Vomiting—Docetaxel—lung cancer	5.85e-06	0.000163	CcSEcCtD
Irinotecan—Dyspepsia—Methotrexate—lung cancer	5.84e-06	0.000163	CcSEcCtD
Irinotecan—Rash—Docetaxel—lung cancer	5.8e-06	0.000162	CcSEcCtD
Irinotecan—Dermatitis—Docetaxel—lung cancer	5.8e-06	0.000161	CcSEcCtD
Irinotecan—Confusional state—Doxorubicin—lung cancer	5.79e-06	0.000161	CcSEcCtD
Irinotecan—Decreased appetite—Methotrexate—lung cancer	5.77e-06	0.000161	CcSEcCtD
Irinotecan—Headache—Docetaxel—lung cancer	5.77e-06	0.000161	CcSEcCtD
Irinotecan—Oedema—Doxorubicin—lung cancer	5.74e-06	0.00016	CcSEcCtD
Irinotecan—Anaphylactic shock—Doxorubicin—lung cancer	5.74e-06	0.00016	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Methotrexate—lung cancer	5.73e-06	0.000159	CcSEcCtD
Irinotecan—Fatigue—Methotrexate—lung cancer	5.72e-06	0.000159	CcSEcCtD
Irinotecan—Infection—Doxorubicin—lung cancer	5.71e-06	0.000159	CcSEcCtD
Irinotecan—Pain—Methotrexate—lung cancer	5.67e-06	0.000158	CcSEcCtD
Irinotecan—Shock—Doxorubicin—lung cancer	5.65e-06	0.000157	CcSEcCtD
Irinotecan—Nervous system disorder—Doxorubicin—lung cancer	5.63e-06	0.000157	CcSEcCtD
Irinotecan—Thrombocytopenia—Doxorubicin—lung cancer	5.62e-06	0.000157	CcSEcCtD
Irinotecan—Hyperhidrosis—Doxorubicin—lung cancer	5.55e-06	0.000155	CcSEcCtD
Irinotecan—Anorexia—Doxorubicin—lung cancer	5.48e-06	0.000152	CcSEcCtD
Irinotecan—Nausea—Docetaxel—lung cancer	5.47e-06	0.000152	CcSEcCtD
Irinotecan—Feeling abnormal—Methotrexate—lung cancer	5.47e-06	0.000152	CcSEcCtD
Irinotecan—Gastrointestinal pain—Methotrexate—lung cancer	5.43e-06	0.000151	CcSEcCtD
Irinotecan—Hypotension—Doxorubicin—lung cancer	5.37e-06	0.000149	CcSEcCtD
Irinotecan—Abdominal pain—Methotrexate—lung cancer	5.24e-06	0.000146	CcSEcCtD
Irinotecan—Body temperature increased—Methotrexate—lung cancer	5.24e-06	0.000146	CcSEcCtD
Irinotecan—Insomnia—Doxorubicin—lung cancer	5.2e-06	0.000145	CcSEcCtD
Irinotecan—Paraesthesia—Doxorubicin—lung cancer	5.16e-06	0.000144	CcSEcCtD
Irinotecan—Dyspnoea—Doxorubicin—lung cancer	5.12e-06	0.000143	CcSEcCtD
Irinotecan—Somnolence—Doxorubicin—lung cancer	5.11e-06	0.000142	CcSEcCtD
Irinotecan—Dyspepsia—Doxorubicin—lung cancer	5.06e-06	0.000141	CcSEcCtD
Irinotecan—Decreased appetite—Doxorubicin—lung cancer	4.99e-06	0.000139	CcSEcCtD
Irinotecan—Gastrointestinal disorder—Doxorubicin—lung cancer	4.96e-06	0.000138	CcSEcCtD
Irinotecan—Fatigue—Doxorubicin—lung cancer	4.95e-06	0.000138	CcSEcCtD
Irinotecan—Constipation—Doxorubicin—lung cancer	4.91e-06	0.000137	CcSEcCtD
Irinotecan—Pain—Doxorubicin—lung cancer	4.91e-06	0.000137	CcSEcCtD
Irinotecan—Hypersensitivity—Methotrexate—lung cancer	4.89e-06	0.000136	CcSEcCtD
Irinotecan—Asthenia—Methotrexate—lung cancer	4.76e-06	0.000132	CcSEcCtD
Irinotecan—Feeling abnormal—Doxorubicin—lung cancer	4.73e-06	0.000132	CcSEcCtD
Irinotecan—Gastrointestinal pain—Doxorubicin—lung cancer	4.7e-06	0.000131	CcSEcCtD
Irinotecan—Body temperature increased—Doxorubicin—lung cancer	4.54e-06	0.000126	CcSEcCtD
Irinotecan—Abdominal pain—Doxorubicin—lung cancer	4.54e-06	0.000126	CcSEcCtD
Irinotecan—Diarrhoea—Methotrexate—lung cancer	4.54e-06	0.000126	CcSEcCtD
Irinotecan—Dizziness—Methotrexate—lung cancer	4.39e-06	0.000122	CcSEcCtD
Irinotecan—Hypersensitivity—Doxorubicin—lung cancer	4.23e-06	0.000118	CcSEcCtD
Irinotecan—Vomiting—Methotrexate—lung cancer	4.22e-06	0.000117	CcSEcCtD
Irinotecan—Rash—Methotrexate—lung cancer	4.18e-06	0.000116	CcSEcCtD
Irinotecan—Dermatitis—Methotrexate—lung cancer	4.18e-06	0.000116	CcSEcCtD
Irinotecan—Headache—Methotrexate—lung cancer	4.16e-06	0.000116	CcSEcCtD
Irinotecan—Asthenia—Doxorubicin—lung cancer	4.12e-06	0.000115	CcSEcCtD
Irinotecan—Nausea—Methotrexate—lung cancer	3.94e-06	0.00011	CcSEcCtD
Irinotecan—Diarrhoea—Doxorubicin—lung cancer	3.93e-06	0.000109	CcSEcCtD
Irinotecan—Dizziness—Doxorubicin—lung cancer	3.8e-06	0.000106	CcSEcCtD
Irinotecan—Vomiting—Doxorubicin—lung cancer	3.65e-06	0.000102	CcSEcCtD
Irinotecan—Rash—Doxorubicin—lung cancer	3.62e-06	0.000101	CcSEcCtD
Irinotecan—Dermatitis—Doxorubicin—lung cancer	3.62e-06	0.000101	CcSEcCtD
Irinotecan—Headache—Doxorubicin—lung cancer	3.6e-06	0.0001	CcSEcCtD
Irinotecan—Nausea—Doxorubicin—lung cancer	3.41e-06	9.5e-05	CcSEcCtD
Irinotecan—ALB—Metabolism—CYP2E1—lung cancer	7.13e-07	3.21e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—APOA1—lung cancer	7.12e-07	3.21e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—CREBBP—lung cancer	7.11e-07	3.2e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—CREBBP—lung cancer	7.11e-07	3.2e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CD—lung cancer	7.1e-07	3.2e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—APOA1—lung cancer	7.06e-07	3.18e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—NQO1—lung cancer	7.05e-07	3.17e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—POMC—lung cancer	7.04e-07	3.17e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CG—lung cancer	7.02e-07	3.16e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—ALB—lung cancer	7.01e-07	3.16e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTP1—lung cancer	6.99e-07	3.14e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ENO1—lung cancer	6.97e-07	3.14e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—IL2—lung cancer	6.97e-07	3.14e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	6.96e-07	3.13e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MDM2—lung cancer	6.95e-07	3.13e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—RRM1—lung cancer	6.95e-07	3.13e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTA3—lung cancer	6.95e-07	3.13e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—RAF1—lung cancer	6.93e-07	3.12e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.9e-07	3.11e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—POMC—lung cancer	6.86e-07	3.09e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—CREBBP—lung cancer	6.85e-07	3.08e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—ERBB2—lung cancer	6.85e-07	3.08e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.84e-07	3.08e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTP1—lung cancer	6.83e-07	3.07e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CAT—lung cancer	6.8e-07	3.06e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PTEN—lung cancer	6.79e-07	3.06e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MTOR—lung cancer	6.76e-07	3.04e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CB—lung cancer	6.76e-07	3.04e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CD4—lung cancer	6.75e-07	3.04e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CD—lung cancer	6.74e-07	3.03e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CD—lung cancer	6.74e-07	3.03e-05	CbGpPWpGaD
Irinotecan—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	6.72e-07	3.03e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTGS2—lung cancer	6.7e-07	3.02e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—POMC—lung cancer	6.69e-07	3.01e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—CREBBP—lung cancer	6.68e-07	3.01e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—ALB—lung cancer	6.65e-07	2.99e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—ALB—lung cancer	6.65e-07	2.99e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CAT—lung cancer	6.65e-07	2.99e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ABCB1—lung cancer	6.61e-07	2.98e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—B4GALT5—lung cancer	6.53e-07	2.94e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	6.52e-07	2.93e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—CREBBP—lung cancer	6.51e-07	2.93e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CG—lung cancer	6.5e-07	2.93e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CD—lung cancer	6.5e-07	2.92e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—TYMS—lung cancer	6.5e-07	2.92e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—EP300—lung cancer	6.48e-07	2.92e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ABCB1—lung cancer	6.46e-07	2.91e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CG—lung cancer	6.45e-07	2.9e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—GSTM1—lung cancer	6.42e-07	2.89e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—ALB—lung cancer	6.41e-07	2.89e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—STK11—lung cancer	6.36e-07	2.86e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTA4—lung cancer	6.35e-07	2.86e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—TYMS—lung cancer	6.35e-07	2.86e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CD—lung cancer	6.34e-07	2.85e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—GSTM1—lung cancer	6.28e-07	2.82e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—ALB—lung cancer	6.25e-07	2.81e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—EP300—lung cancer	6.25e-07	2.81e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP2E1—lung cancer	6.25e-07	2.81e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTA2—lung cancer	6.19e-07	2.79e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—POMC—lung cancer	6.19e-07	2.79e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CB—lung cancer	6.19e-07	2.79e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—NQO1—lung cancer	6.18e-07	2.78e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CD—lung cancer	6.17e-07	2.78e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—POMC—lung cancer	6.14e-07	2.76e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTGS2—lung cancer	6.13e-07	2.76e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—ALB—lung cancer	6.1e-07	2.74e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CYP1A1—lung cancer	6.09e-07	2.74e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—SRC—lung cancer	6.08e-07	2.74e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ERCC2—lung cancer	6.04e-07	2.72e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—CREBBP—lung cancer	6.03e-07	2.71e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—CREBBP—lung cancer	5.98e-07	2.69e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTA1—lung cancer	5.97e-07	2.69e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.97e-07	2.69e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CYP1A1—lung cancer	5.95e-07	2.68e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—VEGFA—lung cancer	5.92e-07	2.66e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCC3—lung cancer	5.91e-07	2.66e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ERCC2—lung cancer	5.9e-07	2.66e-05	CbGpPWpGaD
Irinotecan—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	5.89e-07	2.65e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTP1—lung cancer	5.88e-07	2.65e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CB—lung cancer	5.87e-07	2.64e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CB—lung cancer	5.87e-07	2.64e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—CDKN1A—lung cancer	5.86e-07	2.64e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—NRAS—lung cancer	5.85e-07	2.63e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PTEN—lung cancer	5.84e-07	2.63e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTGS2—lung cancer	5.82e-07	2.62e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTGS2—lung cancer	5.82e-07	2.62e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CAT—lung cancer	5.72e-07	2.58e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKR1C1—lung cancer	5.72e-07	2.58e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CD—lung cancer	5.72e-07	2.57e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.69e-07	2.56e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CD—lung cancer	5.67e-07	2.55e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CB—lung cancer	5.66e-07	2.55e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—ALB—lung cancer	5.64e-07	2.54e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTGS2—lung cancer	5.61e-07	2.53e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—MAPK3—lung cancer	5.6e-07	2.52e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—ALB—lung cancer	5.59e-07	2.52e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EP300—lung cancer	5.57e-07	2.51e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—STK11—lung cancer	5.57e-07	2.51e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ABCB1—lung cancer	5.57e-07	2.51e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—UGT1A1—lung cancer	5.55e-07	2.5e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CB—lung cancer	5.52e-07	2.49e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTGS2—lung cancer	5.47e-07	2.46e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—TYMS—lung cancer	5.47e-07	2.46e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—SRC—lung cancer	5.42e-07	2.44e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—GSTM1—lung cancer	5.4e-07	2.43e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CB—lung cancer	5.38e-07	2.42e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GNG11—lung cancer	5.36e-07	2.41e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PTEN—lung cancer	5.35e-07	2.41e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTGS2—lung cancer	5.33e-07	2.4e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—STAT3—lung cancer	5.23e-07	2.35e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—APOA1—lung cancer	5.22e-07	2.35e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—NRAS—lung cancer	5.21e-07	2.35e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTP1—lung cancer	5.15e-07	2.32e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CYP1A1—lung cancer	5.12e-07	2.31e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—APOA1—lung cancer	5.1e-07	2.3e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—EP300—lung cancer	5.1e-07	2.3e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALDOA—lung cancer	5.1e-07	2.3e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—ERCC2—lung cancer	5.08e-07	2.29e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PTEN—lung cancer	5.08e-07	2.28e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PTEN—lung cancer	5.08e-07	2.28e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—KRAS—lung cancer	5.03e-07	2.27e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CAT—lung cancer	5.01e-07	2.26e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MAPK3—lung cancer	4.99e-07	2.25e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CB—lung cancer	4.98e-07	2.24e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NCOA3—lung cancer	4.95e-07	2.23e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CB—lung cancer	4.94e-07	2.22e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTGS2—lung cancer	4.94e-07	2.22e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTGS2—lung cancer	4.89e-07	2.2e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PTEN—lung cancer	4.89e-07	2.2e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—MYC—lung cancer	4.86e-07	2.19e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—EP300—lung cancer	4.84e-07	2.18e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—EP300—lung cancer	4.84e-07	2.18e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ADCY1—lung cancer	4.82e-07	2.17e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCG2—lung cancer	4.82e-07	2.17e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—PIK3CA—lung cancer	4.79e-07	2.16e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—TYMS—lung cancer	4.79e-07	2.16e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PTEN—lung cancer	4.77e-07	2.15e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CG—lung cancer	4.77e-07	2.15e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—EGFR—lung cancer	4.75e-07	2.14e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—GSTM1—lung cancer	4.74e-07	2.13e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ENO2—lung cancer	4.72e-07	2.13e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—HPGDS—lung cancer	4.72e-07	2.13e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PPP2R1B—lung cancer	4.69e-07	2.11e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—EP300—lung cancer	4.67e-07	2.1e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CG—lung cancer	4.66e-07	2.1e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PTEN—lung cancer	4.65e-07	2.09e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—PIK3CA—lung cancer	4.62e-07	2.08e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTT1—lung cancer	4.58e-07	2.06e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—EP300—lung cancer	4.55e-07	2.05e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—POMC—lung cancer	4.54e-07	2.04e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GCLC—lung cancer	4.53e-07	2.04e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2A6—lung cancer	4.53e-07	2.04e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CYP1A1—lung cancer	4.49e-07	2.02e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—KRAS—lung cancer	4.49e-07	2.02e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—TP53—lung cancer	4.47e-07	2.01e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ERCC2—lung cancer	4.45e-07	2e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—POMC—lung cancer	4.44e-07	2e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—EP300—lung cancer	4.44e-07	2e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—CREBBP—lung cancer	4.42e-07	1.99e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—APOA1—lung cancer	4.4e-07	1.98e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—CREBBP—lung cancer	4.32e-07	1.94e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PTEN—lung cancer	4.31e-07	1.94e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ENO1—lung cancer	4.29e-07	1.93e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—HRAS—lung cancer	4.28e-07	1.93e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PTEN—lung cancer	4.27e-07	1.92e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.21e-07	1.89e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CD—lung cancer	4.19e-07	1.89e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—ALB—lung cancer	4.14e-07	1.86e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—PIK3CA—lung cancer	4.12e-07	1.86e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—EP300—lung cancer	4.11e-07	1.85e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CD—lung cancer	4.1e-07	1.84e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—EP300—lung cancer	4.07e-07	1.83e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—ALB—lung cancer	4.04e-07	1.82e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CG—lung cancer	4.01e-07	1.81e-05	CbGpPWpGaD
Irinotecan—SLC22A3—Metabolism—AKT1—lung cancer	3.92e-07	1.76e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—APOA1—lung cancer	3.85e-07	1.73e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP2E1—lung cancer	3.85e-07	1.73e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—POMC—lung cancer	3.82e-07	1.72e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—HRAS—lung cancer	3.81e-07	1.72e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—NQO1—lung cancer	3.81e-07	1.71e-05	CbGpPWpGaD
Irinotecan—ALB—Hemostasis—AKT1—lung cancer	3.78e-07	1.7e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—PIK3CA—lung cancer	3.77e-07	1.7e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—CREBBP—lung cancer	3.72e-07	1.67e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CB—lung cancer	3.65e-07	1.64e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—IL6—lung cancer	3.65e-07	1.64e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTGS2—lung cancer	3.62e-07	1.63e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—PIK3CA—lung cancer	3.58e-07	1.61e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—PIK3CA—lung cancer	3.58e-07	1.61e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CB—lung cancer	3.57e-07	1.61e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTGS2—lung cancer	3.54e-07	1.59e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CD—lung cancer	3.53e-07	1.59e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CG—lung cancer	3.52e-07	1.58e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—PIK3CA—lung cancer	3.45e-07	1.55e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—STK11—lung cancer	3.43e-07	1.54e-05	CbGpPWpGaD
Irinotecan—ABCC1—Disease—AKT1—lung cancer	3.37e-07	1.52e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—PIK3CA—lung cancer	3.37e-07	1.52e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—POMC—lung cancer	3.35e-07	1.51e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—PIK3CA—lung cancer	3.28e-07	1.48e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—CREBBP—lung cancer	3.26e-07	1.47e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTP1—lung cancer	3.17e-07	1.43e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PTEN—lung cancer	3.16e-07	1.42e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CD—lung cancer	3.09e-07	1.39e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CAT—lung cancer	3.09e-07	1.39e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PTEN—lung cancer	3.09e-07	1.39e-05	CbGpPWpGaD
Irinotecan—ACHE—Metabolism—AKT1—lung cancer	3.08e-07	1.39e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CB—lung cancer	3.08e-07	1.38e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—ALB—lung cancer	3.05e-07	1.37e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTGS2—lung cancer	3.05e-07	1.37e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—PIK3CA—lung cancer	3.04e-07	1.37e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—PIK3CA—lung cancer	3.01e-07	1.36e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—EP300—lung cancer	3.01e-07	1.35e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ABCB1—lung cancer	3.01e-07	1.35e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—TYMS—lung cancer	2.95e-07	1.33e-05	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—EP300—lung cancer	2.94e-07	1.32e-05	CbGpPWpGaD
Irinotecan—UGT1A1—Metabolism—AKT1—lung cancer	2.92e-07	1.32e-05	CbGpPWpGaD
Irinotecan—UGT1A9—Metabolism—AKT1—lung cancer	2.92e-07	1.32e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—GSTM1—lung cancer	2.92e-07	1.31e-05	CbGpPWpGaD
Irinotecan—ABCC1—Metabolism—AKT1—lung cancer	2.82e-07	1.27e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CYP1A1—lung cancer	2.77e-07	1.24e-05	CbGpPWpGaD
Irinotecan—BCHE—Metabolism—AKT1—lung cancer	2.75e-07	1.24e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ERCC2—lung cancer	2.74e-07	1.23e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CB—lung cancer	2.69e-07	1.21e-05	CbGpPWpGaD
Irinotecan—SLCO1B1—Metabolism—AKT1—lung cancer	2.68e-07	1.21e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTGS2—lung cancer	2.67e-07	1.2e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PTEN—lung cancer	2.66e-07	1.2e-05	CbGpPWpGaD
Irinotecan—ALB—Metabolism—EP300—lung cancer	2.53e-07	1.14e-05	CbGpPWpGaD
Irinotecan—ABCG2—Metabolism—AKT1—lung cancer	2.48e-07	1.12e-05	CbGpPWpGaD
Irinotecan—CYP3A7—Metabolism—AKT1—lung cancer	2.46e-07	1.11e-05	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—APOA1—lung cancer	2.37e-07	1.07e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PTEN—lung cancer	2.33e-07	1.05e-05	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—PIK3CA—lung cancer	2.23e-07	1e-05	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—EP300—lung cancer	2.22e-07	9.99e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—PIK3CA—lung cancer	2.18e-07	9.8e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CG—lung cancer	2.17e-07	9.75e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—POMC—lung cancer	2.06e-07	9.28e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—CREBBP—lung cancer	2.01e-07	9.04e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CD—lung cancer	1.9e-07	8.57e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—ALB—lung cancer	1.88e-07	8.46e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—PIK3CA—lung cancer	1.87e-07	8.44e-06	CbGpPWpGaD
Irinotecan—CYP2B6—Metabolism—AKT1—lung cancer	1.82e-07	8.19e-06	CbGpPWpGaD
Irinotecan—CYP3A5—Metabolism—AKT1—lung cancer	1.78e-07	8e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CB—lung cancer	1.66e-07	7.47e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTGS2—lung cancer	1.64e-07	7.4e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—PIK3CA—lung cancer	1.64e-07	7.39e-06	CbGpPWpGaD
Irinotecan—ALB—Metabolism—AKT1—lung cancer	1.53e-07	6.89e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PTEN—lung cancer	1.43e-07	6.46e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—EP300—lung cancer	1.37e-07	6.16e-06	CbGpPWpGaD
Irinotecan—ABCB1—Metabolism—AKT1—lung cancer	1.34e-07	6.04e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—PIK3CA—lung cancer	1.01e-07	4.55e-06	CbGpPWpGaD
Irinotecan—CYP3A4—Metabolism—AKT1—lung cancer	8.27e-08	3.72e-06	CbGpPWpGaD
